AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Fosun Receives Ubs Report: Believes Fosun Can Effectively Manage Financing Risks

Jul 04, 2022•about 3 years ago

Description

Fosun International Limited (HKEX stock code: 00656, "Fosun International") said that UBS has recently published a report on Fosun International. UBS believes that Fosun can effectively manage near-term financing risks and assigned Fosun a "neutral" rating with a 12-month target price of HK$9.1.

Company Information

Company

Fosun

About

Founded in 1992, Fosun is a global innovation-driven consumer group dedicated to providing high-quality products and services for families around the world in Health, Happiness, Wealth, and Intelligent Manufacturing segments. In 2007, Fosun International Limited was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK). In 2021, Fosun International's total revenue was RMB161.3 billion and total assets amounted to RMB806.4 billion. Fosun International ranks No.589 on the 2022 Forbes Global 2000 List, with a MSCI ESG rating of AA. SOURCE Fosun

Company News

(10 articles)

Wed, 18 Jun 2025 07:00:00 GMT

Teva and Fosun Pharma partner on early-stage oncology drug - PharmaTimes

Wed, 04 Jun 2025 07:00:00 GMT

Dine Around Downtown Returns, Bringing 48 Lower Manhattan Restaurants to Fosun Plaza on June 11 - citybiz

Tue, 28 Mar 2023 07:00:00 GMT

Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement - PR Newswire

Mon, 10 Mar 2025 07:00:00 GMT

Gleneagles, Fosun Health partner for enhanced medical integration in GBA - Healthcare Asia Magazine

Fri, 31 Aug 2018 07:00:00 GMT

Fosun Pharma ‘massively’ fakes API production data and bribes regulators, whistleblower says - Fierce Pharma

Tue, 19 Mar 2024 07:00:00 GMT

Exclusive: Fosun open to sale of Portuguese bank stake, sources say - Reuters

Wed, 31 Mar 2021 07:00:00 GMT

China's Fosun Says Willing to Supply BioNTech and Pfizer Vaccine to Taiwan - Bloomberg.com

Wed, 04 Nov 2020 08:00:00 GMT

Fosun follows BioNTech in changing COVID-19 vaccine, plans bridging study for Chinese filing - Fierce Biotech

Tue, 14 May 2024 18:30:11 GMT

Joann Cheng | BoF 500 | The People Shaping the Global Fashion Industry - The Business of Fashion

Wed, 19 Oct 2022 07:00:00 GMT

Fosun divestments near $5bn as debt pressure mounts - Financial Times

FundzWatch™ Score

Medium Activity